Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06761612 · ClinicalTrials.gov registry record

Retail COVID-19 Study

A clinical trial of COVID-19, sponsored by Biomedical Advanced Research and Development Authority.

Active
Registry status
2,660
Enrollment target
20
Study locations

NCT06761612 is a study of COVID-19 that is active but no longer recruiting, run by Biomedical Advanced Research and Development Authority. The registered enrollment target is 2,660 participants, below the 55,201-participant average among 203 other COVID-19 trials with a reported enrollment target (95% lower). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06761612, a study of COVID-19, is active but no longer recruiting, sponsored by Biomedical Advanced Research and Development Authority.

ACTIVE NOT RECRUITING
Registry status
2,660 participants
Enrollment target
20
Study locations

Study Summary

Despite the availability of vaccines, there remains a need to identify specific immune responses that correlate with protection against SARS-CoV-2 infection. Additionally, the operational capability of retail pharmacy infrastructure to collect longitudinal data and biological samples needs to be assessed. This study aims to fill these gaps by determining correlates of protection (CoP), assessing the infrastructure's capability, and examining demographic and geographic differences in participation.

Conditions Studied

COVID-19

Interventions

  • BIOLOGICAL FDA approved mRNA vaccines

Study Locations (20)

Texas

  • Walgreens - 420 N Frazier St - Conroe
  • Walgreens - 1919 W Gray St - Houston
  • Walgreens - 7440 FM 1960 Rd E - Humble
  • Walgreens - 8430 Broadway St - Pearland
  • Walgreens - 3316 Avenue H - Rosenberg

Illinois

  • Walgreens - 1554 E 55th St - Chicago
  • Walgreens - 4385 S Archer Ave - Chicago
  • Walgreens - 811 Madison St - Oak Park
  • Walgreens - 7251 Lake St - River Forest

Missouri

  • Walgreens - 17811 E US Highway 24 - Independence
  • Walgreens - 3845 Broadway Blvd - Kansas City
  • Walgreens - 2630 NE Vivion - Kansas City

Kansas

  • Walgreens - 15100 W 87th Street Pkwy - Lenexa
  • Walgreens - 7500 Metcalf Ave - Overland Park

Nevada

  • Walgreens - 6401 W Charleston Blvd - Las Vegas
  • Walgreens - 1445 W Craig Rd - North Las Vegas

New Jersey

  • Walgreens - 3218 Atlantic Ave - Atlantic City
  • Walgreens - 520 Convery Blvd - Perth Amboy

Florida

  • Walgreens - 3298 S John Young Pkwy - Kissimmee

Massachusetts

  • Walgreens - 215 Beach St - Malden

Trial Details

FieldValue
Enrollment Target 2,660 participants
Start Date 2024-10-19
Est. Completion 2026-05

Sponsor

Biomedical Advanced Research and Development Authority

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06761612

The ClinicalTrials.gov registry entry for NCT06761612 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,660 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,201-participant average among 203 other COVID-19 trials with a reported enrollment target (95% lower). The listed sponsor is Biomedical Advanced Research and Development Authority, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which FDA approved mRNA vaccines is the first listed.

NCT06761612 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Texas, Illinois, Missouri.

Frequently Asked Questions

What is clinical trial NCT06761612 about?

NCT06761612 is a clinical study titled "Retail COVID-19 Study". Despite the availability of vaccines, there remains a need to identify specific immune responses that correlate with protection against SARS-CoV-2 infection. Additionally, the operational capability of retail pharmacy infrastructure to collect longitudinal data and biological samples needs to be ass...

What is the current status of trial NCT06761612?

This trial is currently active not recruiting. The enrollment target is 2,660 participants. The study started on 2024-10-19. Estimated completion is 2026-05.

What conditions does trial NCT06761612 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT06761612?

The interventions under investigation include: FDA approved mRNA vaccines (BIOLOGICAL).

Who is sponsoring clinical trial NCT06761612?

This trial is sponsored by Biomedical Advanced Research and Development Authority, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06761612 being conducted?

This trial has 20 study locations across Florida, Illinois, Kansas, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.